StonvexLoading…
StonvexCore line items from FLR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $15.50B | $16.32B | $15.47B | $13.74B |
Operating Income | $-378.00M | $463.00M | $147.00M | $209.00M |
Net Income | $-51.00M | $2.15B | $139.00M | $145.00M |
EPS (Diluted) | $-0.31 | $12.30 | $0.54 | $0.73 |
Total Assets | $8.24B | $9.14B | $6.97B | $6.83B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $2.13B | $2.83B | $2.52B | $2.44B |
Free Cash Flow OCF − CapEx | $-437.00M | $664.00M | $106.00M | $-44.00M |
Shares Outstanding | 152.05M | 169.23M | 170.41M | 142.32M |